OncoSec Medical Incorporated ONCSQ
OTC PK
| 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | 01/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 28.25% | 22.32% | -- | -- | -- |
| Total Depreciation and Amortization | -7.23% | 24.92% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -62.42% | -12.43% | -- | -- | -- |
| Change in Net Operating Assets | 142.20% | 101.15% | -- | -- | -- |
| Cash from Operations | 39.16% | 32.27% | -- | -- | -- |
| Capital Expenditure | 97.09% | 19.60% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 98.55% | 69.37% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -11.68% | -50.29% | -- | -- | -- |
| Issuance of Common Stock | -57.14% | -99.62% | -- | -- | -- |
| Repurchase of Common Stock | 92.83% | 91.32% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,073.56% | -103.81% | -- | -- | -- |
| Cash from Financing | -48.13% | -102.09% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -70.82% | -3,315.52% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 38.61% | -355.54% | -- | -- | -- |